Top

Gepubliceerd in:

22-02-2022

Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework

Auteurs: Mallory K. Ellingson, Robert A. Bednarczyk, Sean T. O’Leary, Jason L. Schwartz, Eugene D. Shapiro, Linda M. Niccolai

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 1-2/2023

Abstract

Health care provider recommendations are among the most important factors influencing parents’ decisions to vaccinate their adolescents. However, delivery of high-quality health care provider recommendations for vaccination is not universal. There is wide variation in the strength, timeliness and consistency of the delivery of recommendations for all adolescent vaccines. The factors that influence health care providers’ recommendations are multi-level and can be conceptualized in much the same way as vaccine acceptance among parents. Health care providers are influenced by their own attitudes and beliefs about a vaccine and also by the patient they are treating and by the community in which they practice as well as state and national level vaccine policy. We propose a multi-level framework for understanding the factors that influence health care providers’ recommendations at the individual, interpersonal and community level to both develop and adapt interventions to improve providers’ recommendations.

vorige artikel Therapist disclosure to combat COVID-19 vaccine hesitancy: a narrative review

volgende artikel Using Behavioral Science to Address COVID-19 Vaccine Hesitancy Among Cancer Survivors: Communication Strategies and Research Opportunities

Abdullahi, L. H., Kagina, B. M., Ndze, V. N., Hussey, G. D., & Wiysonge, C. S. (2020). Improving vaccination uptake among adolescents. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD011895CrossRefPubMedPubMedCentral

Amboree, T. L., & Darkoh, C. (2020). Barriers to human papillomavirus vaccine uptake among racial/ethnic minorities: A systematic review. Journal of Racial and Ethnic Health Disparities. https://doi.org/10.1007/s40615-020-00877-6CrossRefPubMedPubMedCentral

American Academy of Pediatrics. (2021). Reporting encounters for immunization safety counseling. AAP Pediatric Coding Newsletter, 16(12), 5–6. https://doi.org/10.1542/pcco_book209_document002CrossRef

Bednarczyk, R. A., Chamberlain, A., Mathewson, K., Salmon, D. A., & Omer, S. B. (2018). Practice-, provider-, and patient-level interventions to improve preventive care: Development of the P3 Model. Preventive Medicine Reports, 11, 131–138. https://doi.org/10.1016/j.pmedr.2018.06.009CrossRefPubMedPubMedCentral

Bednarczyk, R. A., Ellingson, M. K., & Omer, S. B. (2019). Human papillomavirus vaccination before 13 and 15 years of age: Analysis of national immunization survey teen data. The Journal of Infectious Diseases, 220(5), 730–734. https://doi.org/10.1093/infdis/jiy682CrossRefPubMedPubMedCentral

Bernstein, S., North, A., Schwartz, J., & Niccolai, L. M. (2016). State-level voting patterns and adolescent vaccination coverage in the United States, 2014. American Journal of Public Health, 106(10), 1879–1881. https://doi.org/10.2105/AJPH.2016.303381CrossRefPubMedPubMedCentral

Betsch, C., Schmid, P., Heinemeier, D., Korn, L., Holtmann, C., & Böhm, R. (2018). Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE. https://doi.org/10.1371/journal.pone.0208601CrossRefPubMedPubMedCentral

Brewer, N. T., Chapman, G. B., Rothman, A. J., Leask, J., & Kempe, A. (2017). Increasing vaccination: Putting psychological science into action. Psychological Science in the Public Interest, 18(3), 149–207. https://doi.org/10.1177/1529100618760521CrossRefPubMed

Brewer, N. T., Hall, M. E., Malo, T. L., Gilkey, M. B., Quinn, B., & Lathren, C. (2017). Announcements versus conversations to improve HPV vaccination coverage: A randomized trial. Pediatrics. https://doi.org/10.1542/peds.2016-1764CrossRefPubMedPubMedCentral

Caldwell, A. C., Madden, C. A., Thompson, D. M., Garbe, M. C., Roberts, J. R., Jacobson, R. M., & Darden, P. M. (2020). The impact of provider recommendation on human papillomavirus vaccine and other adolescent vaccines. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2020.1817713CrossRef

Cataldi, J. R., O’Leary, S. T., Markowitz, L. E., Allison, M. A., Crane, L. A., Hurley, L. P., Brtnikova, M., Beaty, B. L., Gorman, C., Meites, E., Lindley, M. C., & Kempe, A. (2021). Changes in strength of recommendation and perceived barriers to human papillomavirus vaccination: Longitudinal analysis of primary care physicians, 2008–2018. The Journal of Pediatrics, 234, 149–157. https://doi.org/10.1016/j.jpeds.2021.03.002CrossRefPubMed

CDC. (2020a, February 11). COVID-19 vaccination. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/adolescents.html

CDC. (2020b, November 17). HPV cancers. Centers for Disease Control and Prevention. https://www.cdc.gov/hpv/parents/cancer.html

Centers for Disease Prevention and Control. (2011). Ten great public health achievements—worldwide, 2001–2010. MMWR. Morbidity and Mortality Weekly Report, 60(24), 814–818.

Cohn, A., & MacNeil, J. (2015). The changing epidemiology of meningococcal disease. Infectious Disease Clinics of North America, 29(4), 667–677. https://doi.org/10.1016/j.idc.2015.08.002CrossRefPubMed

Cunningham-Erves, J., Koyama, T., Huang, Y., Jones, J., Wilkins, C. H., Harnack, L., McAfee, C., & Hull, P. C. (2019). Providers’ perceptions of parental human papillomavirus vaccine hesitancy: Cross-sectional study. JMIR Cancer. https://doi.org/10.2196/13832CrossRefPubMedPubMedCentral

Dang, J. H. T., Stewart, S. L., Blumberg, D. A., Rodriguez, H. P., & Chen, M. S. (2020). “There’s Always Next Year”: Primary care team and parent perspectives on the human papillomavirus vaccine. Human Vaccines & Immunotherapeutics, 16(8), 1814–1823. https://doi.org/10.1080/21645515.2019.1710410CrossRef

Dempsey, A. F., & O’Leary, S. T. (2018). Human papillomavirus vaccination: Narrative review of studies on how providers’ vaccine communication affects attitudes and uptake. Academic Pediatrics, 18(2S), S23–S27. https://doi.org/10.1016/j.acap.2017.09.001CrossRefPubMed

Dempsey, A. F., Pyrzanowski, J., Campagna, E. J., Lockhart, S., & O’Leary, S. T. (2019). Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention. Vaccine, 37(10), 1307–1312. https://doi.org/10.1016/j.vaccine.2019.01.051CrossRefPubMed

Dempsey, A. F., Pyrznawoski, J., Lockhart, S., Barnard, J., Campagna, E. J., Garrett, K., Fisher, A., Dickinson, L. M., & O’Leary, S. T. (2018). Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: A cluster randomized clinical trial. JAMA Pediatrics, 172(5), e180016. https://doi.org/10.1001/jamapediatrics.2018.0016CrossRefPubMedPubMedCentral

Do, E. K., Rossi, B., Miller, C. A., Ksinan, A. J., Wheeler, D. C., Chukmaitov, A., Cyrus, J. W., & Fuemmeler, B. F. (2020). Area-level variation and human papillomavirus vaccination among adolescents and young adults in the United States: A systematic review. Cancer Epidemiology and Prevention Biomarkers. https://doi.org/10.1158/1055-9965.EPI-20-0617CrossRef

Elam-Evans, L. D. (2020). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2019. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6933a1

Farias, A. J., Savas, L. S., Fernandez, M. E., Coan, S. P., Shegog, R., Healy, C. M., Lipizzi, E., & Vernon, S. W. (2017). Association of physicians perceived barriers with human papillomavirus vaccination initiation. Preventive Medicine, 105, 219–225. https://doi.org/10.1016/j.ypmed.2017.07.016CrossRefPubMedPubMedCentral

Gilkey, M. B., Calo, W. A., Moss, J. L., Shah, P. D., Marciniak, M. W., & Brewer, N. T. (2016). Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine, 34(9), 1187–1192. https://doi.org/10.1016/j.vaccine.2016.01.023CrossRefPubMedPubMedCentral

Gilkey, M. B., Malo, T. L., Shah, P. D., Hall, M. E., & Brewer, N. T. (2015). Quality of physician communication about human papillomavirus vaccine: Findings from a national survey. Cancer Epidemiology, Biomarkers & Prevention, 24(11), 1673–1679. https://doi.org/10.1158/1055-9965.EPI-15-0326CrossRef

Gilkey, M. B., & McRee, A.-L. (2016). Provider communication about HPV vaccination: A systematic review. Human Vaccines & Immunotherapeutics, 12(6), 1454–1468. https://doi.org/10.1080/21645515.2015.1129090CrossRef

Gowda, C., & Dempsey, A. F. (2012). Medicaid reimbursement and the uptake of adolescent vaccines. Vaccine, 30(9), 1682–1689. https://doi.org/10.1016/j.vaccine.2011.12.097CrossRefPubMed

Grohskopf, L. A., Alyanak, E., Broder, K. R., Blanton, L. H., Fry, A. M., Jernigan, D. B., & Atmar, R. L. (2020). Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization practices—United States, 2020–21 influenza season. MMWR Recommendations and Reports, 69(8), 1–24.CrossRefPubMedPubMedCentral

Hansen, C. E., North, A., & Niccolai, L. M. (2020). Cognitive Bias in clinicians’ communication about human papillomavirus vaccination. Health Communication, 35(4), 430–437. https://doi.org/10.1080/10410236.2019.1567439CrossRefPubMed

Havers, F. P., Moro, P. L., Hunter, P., Hariri, S., & Bernstein, H. (2020). Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: Updated recommendations of the Advisory Committee on Immunization Practices—United States, 2019. Morbidity and Mortality Weekly Report, 69(3), 77–83.CrossRefPubMedPubMedCentral

Henrikson, N. B., Tuzzio, L., Gilkey, M. B., & McRee, A.-L. (2016). “You’re never really off time”: Healthcare providers’ interpretations of optimal timing for HPV vaccination. Preventive Medicine Reports, 4, 94–97. https://doi.org/10.1016/j.pmedr.2016.05.002CrossRefPubMedPubMedCentral

Hopfer, S., Wright, M. E., Pellman, H., Wasserman, R., & Fiks, A. G. (2019). HPV vaccine recommendation profiles among a national network of pediatric practitioners: Understanding contributors to parental vaccine hesitancy and acceptance. Human Vaccines & Immunotherapeutics, 15(7–8), 1776–1783. https://doi.org/10.1080/21645515.2018.1560771CrossRef

Huang, L., Goren, A., Lee, L. K., Li, V. W., Dempsey, A., & Srivastava, A. (2020). Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcal vaccine recommendations. Human Vaccines & Immunotherapeutics, 16(4), 933–944. https://doi.org/10.1080/21645515.2019.1682845CrossRef

Kempe, A., Allison, M. A., MacNeil, J. R., O’Leary, S. T., Crane, L. A., Beaty, B. L., Hurley, L. P., Brtnikova, M., Lindley, M. C., & Albert, A. P. (2018). Adoption of serogroup B meningococcal vaccine recommendations. Pediatrics, 142(3), e20180344. https://doi.org/10.1542/peds.2018-0344CrossRefPubMed

Kempe, A., O’Leary, S. T., Markowitz, L. E., Crane, L. A., Hurley, L. P., Brtnikova, M., Beaty, B. L., Meites, E., Stokley, S., & Lindley, M. C. (2019). HPV vaccine delivery practices by primary care physicians. Pediatrics, 144(4), e20191475. https://doi.org/10.1542/peds.2019-1475CrossRefPubMed

Kester, L. M., Zimet, G. D., Fortenberry, J. D., Kahn, J. A., & Shew, M. L. (2013). A national study of HPV vaccination of adolescent girls: Rates, predictors, and reasons for non-vaccination. Maternal and Child Health Journal, 17(5), 879–885. https://doi.org/10.1007/s10995-012-1066-zCrossRefPubMedPubMedCentral

Lake, P., Kasting, M. L., Malo, T., Giuliano, A. R., & Vadaparampil, S. T. (2019). An environmental scan to examine stakeholder perspectives on human papillomavirus vaccination: A mixed methods study. Vaccine, 37(1), 187–194. https://doi.org/10.1016/j.vaccine.2018.06.073CrossRefPubMed

Lake, P. W., Kasting, M. L., Christy, S. M., & Vadaparampil, S. T. (2019). Provider perspectives on multilevel barriers to HPV vaccination. Human Vaccines & Immunotherapeutics, 15(7–8), 1784–1793. https://doi.org/10.1080/21645515.2019.1581554CrossRef

Leung, S. O. A., Akinwunmi, B., Elias, K. M., & Feldman, S. (2019). Educating healthcare providers to increase human papillomavirus (HPV) vaccination rates: A qualitative systematic review. Vaccine X, 3, 100037. https://doi.org/10.1016/j.jvacx.2019.100037CrossRefPubMedPubMedCentral

MacNeil, J. R., Blain, A. E., Wang, X., & Cohn, A. C. (2018). Current epidemiology and trends in meningococcal disease—United States, 1996–2015. Clinical Infectious Diseases, 66(8), 1276–1281. https://doi.org/10.1093/cid/cix993CrossRefPubMed

Markowitz, L. E., Dunne, E. F., Saraiya, M., Chesson, H. W., Curtis, C. R., Gee, J., Bocchini, J. A., Unger, E. R., & Centers for Disease Control and Prevention (CDC). (2014). Human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports, 63(RR-05), 1–30.

Markowitz, L. E., Gee, J., Chesson, H., & Stokley, S. (2018). Ten years of human papillomavirus vaccination in the United States. Academic Pediatrics, 18(2S), S3–S10. https://doi.org/10.1016/j.acap.2017.09.014CrossRefPubMed

Marshall, G. S., Dempsey, A. F., Srivastava, A., & Isturiz, R. E. (2019). US college students are at increased risk for serogroup B meningococcal disease. Journal of the Pediatric Infectious Diseases Society, 9(2), 244–247. https://doi.org/10.1093/jpids/piz024CrossRefPubMedCentral

Mbaeyi, S. A., Bozio, C. H., Duffy, J., Rubin, L. G., Hariri, S., Stephens, D. S., & MacNeil, J. R. (2020). Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020. MMWR Recommendations and Reports, 69(9), 1–41.CrossRefPubMedPubMedCentral

Mbaeyi, S. A., Joseph, S. J., Blain, A., Wang, X., Hariri, S., & MacNeil, J. R. (2019). Meningococcal disease among college-aged young adults: 2014–2016. Pediatrics. https://doi.org/10.1542/peds.2018-2130CrossRefPubMed

Mohammed, K. A., Geneus, C. J., Osazuwa-Peters, N., Adjei Boakye, E., Tobo, B. B., & Burroughs, T. E. (2016). Disparities in provider recommendation of human papillomavirus vaccination for US adolescents. Journal of Adolescent Health, 59(5), 592–598. https://doi.org/10.1016/j.jadohealth.2016.06.005CrossRef

Mulligan, K., Snider, J. T., Arthur, P., Frank, G., Tebeka, M., Walker, A., & Abrevaya, J. (2018). Examination of universal purchase programs as a driver of vaccine uptake among US States, 1995–2014. Vaccine, 36, 4032–4038.CrossRefPubMed

Niccolai, L. M., & Hansen, C. E. (2015). Practice- and community-based interventions to increase human papillomavirus vaccine coverage: A systematic review. JAMA Pediatrics, 169(7), 686–692. https://doi.org/10.1001/jamapediatrics.2015.0310CrossRefPubMedPubMedCentral

Niccolai, L. M., North, A. L., Footman, A., & Hansen, C. E. (2018). Lack of school requirements and clinician recommendations for human papillomavirus vaccination. Journal of Public Health Research, 7(1), 1324. https://doi.org/10.4081/jphr.2018.1324CrossRefPubMedPubMedCentral

Niccolai, L. M., & Pettigrew, M. M. (2016). The role of cognitive bias in suboptimal HPV vaccine uptake. Pediatrics. https://doi.org/10.1542/peds.2016-1537CrossRefPubMed

Niccolai, L. M., Yakely, A. E., & Hansen, C. E. (2019). Up-to-date coverage with meningococcal vaccine among adolescents age 17 years: Patterns and correlates in the United States, 2017. Vaccine, 37(40), 5934–5938. https://doi.org/10.1016/j.vaccine.2019.08.015CrossRefPubMed

Oh, N. L., Biddell, C. B., Rhodes, B. E., & Brewer, N. T. (2021). Provider communication and HPV vaccine uptake: A meta-analysis and systematic review. Preventive Medicine. https://doi.org/10.1016/j.ypmed.2021.106554CrossRefPubMed

Opel, D. J., Heritage, J., Taylor, J. A., Mangione-Smith, R., Salas, H. S., Devere, V., Zhou, C., & Robinson, J. D. (2013). The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics, 132(6), 1037–1046. https://doi.org/10.1542/peds.2013-2037CrossRefPubMedPubMedCentral

Patel, B. (2021). Impact of the COVID-19 Pandemic on administration of selected routine childhood and adolescent vaccinations—10 U.S. Jurisdictions, March–September 2020. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7023a2

Rodriguez, S. A., Mullen, P. D., Lopez, D. M., Savas, L. S., & Fernández, M. E. (2020). Factors associated with adolescent HPV vaccination in the US: A systematic review of reviews and multilevel framework to inform intervention development. Preventive Medicine, 131, 105968. https://doi.org/10.1016/j.ypmed.2019.105968CrossRefPubMed

Schaffer DeRoo, S., Torres, R. G., & Fu, L. Y. (2021). Meningococcal disease and vaccination in college students. Human Vaccines & Immunotherapeutics, 17(11), 4675–4688. https://doi.org/10.1080/21645515.2021.1973881CrossRef

Sonawane, K., Lin, Y.-Y., Damgacioglu, H., Zhu, Y., Fernandez, M. E., Montealegre, J. R., Cazaban, C. G., Li, R., Lairson, D. R., Lin, Y., Giuliano, A. R., & Deshmukh, A. A. (2021). Trends in human papillomavirus vaccine safety concerns and adverse event reporting in the United States. JAMA Network Open, 4(9), e2124502. https://doi.org/10.1001/jamanetworkopen.2021.24502CrossRefPubMedPubMedCentral

Stokley, S., & Szilagyi, P. G. (2018). Improving human papillomavirus vaccination in the United States: Executive summary. Academic Pediatrics, 18(2S), S1–S2. https://doi.org/10.1016/j.acap.2018.01.009CrossRefPubMedPubMedCentral

Suryadevara, M., Handel, A., Bonville, C. A., Cibula, D. A., & Domachowske, J. B. (2015). Pediatric provider vaccine hesitancy: An under-recognized article in immunizing children. Vaccine, 33, 6629–6634.CrossRefPubMed

Szilagyi, P. G., Humiston, S. G., Stephens-Shields, A. J., Localio, R., Breck, A., Kelly, M. K., Wright, M., Grundmeier, R. W., Albertin, C., Shone, L. P., Steffes, J., Rand, C. M., Hannan, C., Abney, D. E., McFarland, G., Kominski, G. F., Seixas, B. V., & Fiks, A. G. (2021). Effect of training pediatric clinicians in human papillomavirus communication strategies on human papillomavirus vaccination rates: A cluster randomized clinical trial. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2021.0766CrossRefPubMedPubMedCentral

The SAGE Vaccine Hesitancy Working Group. (2013). What influences vaccine acceptance: A model of determinants of vaccine hesitancy. Geneva: WHO. https://www.who.int/immunization/sage/meetings/2013/april/1_Model_analyze_driversofvaccineConfidence_22_March.pdf

Tsai, Y., Lindley, M. C., Zhou, F., & Stokley, S. (2018). Provider payments and the receipt of human papillomavirus vaccine among privately insured adolescents. Health Affairs, 37(10), 1587–1595. https://doi.org/10.1377/hlthaff.2018.0545CrossRefPubMed

Vaccination—Healthy People 2030 | health.gov. (n.d.). Retrieved March 24, 2021, from https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination

Vu, M., Berg, C. J., Escoffery, C., Jang, H. M., Nguyen, T. T., Travis, L., & Bednarczyk, R. A. (2020). A systematic review of practice-, provider-, and patient-level determinants impacting Asian-Americans’ human papillomavirus vaccine intention and uptake. Vaccine, 38(41), 6388–6401. https://doi.org/10.1016/j.vaccine.2020.07.059CrossRefPubMedPubMedCentral

Warner, E. L., Ding, Q., Pappas, L. M., Henry, K., & Kepka, D. (2017). White, affluent, educated parents are least likely to choose HPV vaccination for their children: A cross-sectional study of the National Immunization Study—teen. BMC Pediatrics, 17(1), 200. https://doi.org/10.1186/s12887-017-0953-2CrossRefPubMedPubMedCentral

Titel: Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework
Auteurs: Mallory K. Ellingson
Robert A. Bednarczyk
Sean T. O’Leary
Jason L. Schwartz
Eugene D. Shapiro
Linda M. Niccolai
Publicatiedatum: 22-02-2022
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 1-2/2023
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-022-00296-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 1-2/2023

Addressing racial/ethnic inequities in vaccine hesitancy and uptake: lessons learned from the California alliance against COVID-19

Scaling up the discovery of hesitancy profiles by identifying the framing of beliefs towards vaccine confidence in Twitter discourse

Factors associated with mothers’ hesitancy to receive a COVID-19 vaccine

Hesitant but vaccinated: assessing COVID-19 vaccine hesitancy among the recently vaccinated

The Effect of Science-Related Populism on Vaccination Attitudes and Decisions

COVID-19 vaccine uptake and attitudes towards mandates in a nationally representative U.S. sample